Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28083
Abstract: To the Editor: We read with interest the paper by Sinha et al regarding initial results from the off-label use of the Edwards SAPIEN 3 (S3) valve for percutaneous transcatheter pulmonary valve implantation. The introduction… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29461
Abstract: Severe symptomatic tricuspid regurgitation (TR) remains an undertreated disease. Multiple trans‐catheter treatment options are currently under investigation. Transcatheter caval valve implantation (CAVI) has been utilized as a treatment option and aims at decreasing or eliminating… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30114
Abstract: Investigate the impact of concomitant tricuspid regurgitation (TR) on clinical outcomes during long‐term follow‐up in patients undergoing percutaneous treatment of mitral regurgitation (MR) with the MitraClip system. read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30221
Abstract: Patients with symptomatic significant mitral regurgitation undergoing mitral transcatheter edge ‐ to ‐ edge repair (TEER) and concomitant tricuspid regurgitation (TR) represent a heteroge-nous population, given they may have underlying left ‐ sided, right ‐… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30450
Abstract: Severe tricuspid regurgitation (TR) is independently associated with increased morbidity and mortality. Percutaneous transcatheter approaches may offer an alternative for patients not amenable to surgery. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12906
Abstract: Arrhythmogenic cardiomyopathy (AC) is characterized by right ventricular (RV) dilatation and dysfunction and is often seen in combination with tricuspid regurgitation (TR). The aim of this study was to investigate the characteristics and prognostic implications… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13831
Abstract: Several new percutaneous tricuspid repair systems have recently been introduced as new treatment options for severe tricuspid regurgitation (TR). Clinical improvement following percutaneous tricuspid valve leaflet repair has been demonstrated by recent studies. A possible… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.1547
Abstract: Transcatheter tricuspid valve repair (TTVR) is an emerging technique to treat tricuspid regurgitation (TR). Predictors of adverse outcomes are scarce, and stratification by TR aetiologies is lacking. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2637
Abstract: To evaluate short‐term changes in tricuspid regurgitation (TR) after transcatheter edge‐to‐edge mitral valve repair (M‐TEER) in secondary mitral regurgitation (SMR), their predictors and impact on mortality. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Herz"
DOI: 10.1007/s00059-017-4594-x
Abstract: BackgroundAdult patients with undiagnosed atrial septal defect (ASD) may have right heart cavity enlargement and functional tricuspid valve insufficiency. Moderate or more severe tricuspid regurgitation has been associated with a worse prognosis, and more serious complications… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-017-0266-2
Abstract: BackgroundPrior studies report permanent pacemaker (PPM)-induced tricuspid regurgitation (TR) in up to one third of cases late post-implantation. We sought to assess the extent of immediate PPM-induced TR.MethodsForty patients undergoing PPM implant were prospectively enrolled.… read more here.